About
Small Molecules?
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (30)
View allTotal Trials
30
As Lead Sponsor
21
As Collaborator
9
Total Enrollment
11,847
By Phase
PHASE3: 9PHASE1: 4PHASE2: 11PHASE4: 1PHASE2/PHASE3: 2
By Status
COMPLETED: 11TERMINATED: 6ACTIVE_NOT_RECRUITING: 5UNKNOWN: 5RECRUITING: 2NOT_YET_RECRUITING: 1
Clinical Trials Pipeline30 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06865417Lead Sponsor
A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
PHASE3Not yet recruiting
80 participants
Started: Sep 30, 2025 · Completed: Jun 30, 2028
NCT06222034Lead Sponsor
Study to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)
PHASE1Recruiting
10 participants
Started: May 13, 2024 · Completed: Aug 31, 2026
NCT06285539Collaborator
Drug Rediscovery for Rare Immune Mediated Inflammatory Diseases
PHASE2Recruiting
60 participants
Started: Mar 12, 2024 · Completed: Dec 31, 2026
NCT05817942Lead Sponsor
Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
N/AActive, not recruiting
520 participants
Started: Jun 12, 2023 · Completed: Dec 31, 2027
NCT05371925Collaborator
Endothelial Protection in Post COVID-19 Patients With Sulodexide
PHASE3Completed
206 participants
Started: Jun 1, 2023 · Completed: Apr 19, 2024
Locations (1)
Headquarters
Bologna, Italy
Map
Loading map...